Epidiolex

DRUG11 trials

Conditions

AutismAutism Spectrum DisorderBipolar DisorderBirth Outcomes, AdverseCBDEpilepsyMaternal ComplicationsMucopolysaccharidosis III

Early Phase 1

Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers

TerminatedNCT04231643

University of California, San DiegoBipolar Disorder

Start: 2021-09-01End: 2023-11-28Updated: 2024-05-10

Phase 1

University of Alabama at Birmingham (UAB) Pediatric CBD Program

CompletedNCT02695537

University of Alabama at BirminghamEpilepsy, Seizures

Start: 2015-04-30End: 2019-02-27Updated: 2020-04-10

University of Alabama at Birmingham (UAB) Adult CBD Program

CompletedNCT02700412

University of Alabama at BirminghamEpilepsy, Seizures

Start: 2015-04-30End: 2019-08-08Updated: 2020-05-08

Oral Cannabidiol for Opioid Withdrawal

CompletedNCT04238754

Johns Hopkins UniversityOpioid Craving, Opioid Use Disorder, Opioid Withdrawal

Start: 2020-11-01End: 2022-06-30Updated: 2023-08-29

Investigation of the Pharmacokinetic Profile of CBD

CompletedNCT05269706

Yasmin HurdOpioid Use Disorder

Start: 2022-05-18End: 2023-02-16Updated: 2025-02-14

CBD for Pain Following Orthopedic Shoulder Surgery

RecruitingNCT06381791

The Methodist Hospital Research InstituteRotator Cuff Injuries, Shoulder Osteoarthritis

Start: 2024-05-24End: 2027-12-30Target: 80Updated: 2026-03-18

Effects of Cannabidiol on Stress and Nicotine Withdrawal

RecruitingNCT07001930

Johns Hopkins UniversityCBD, Nicotine Dependence, Stress +1

Start: 2025-08-25End: 2029-09-01Target: 90Updated: 2025-09-02

Phase 2

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

Active, not recruitingNCT04517799

University of California, San DiegoAutism, Autism Spectrum Disorder

Start: 2020-06-01End: 2025-12-31Updated: 2025-09-30

Study of Cannabidiol in Sanfilippo Syndrome

Not yet recruitingNCT06333041

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterMucopolysaccharidosis III, Sanfilippo Syndrome

Start: 2026-03-15End: 2028-07-01Target: 35Updated: 2026-02-27

Unknown Phase

Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

Active, not recruitingNCT05772429

Jazz PharmaceuticalsSeizures

Start: 2023-04-17End: 2026-07-31Updated: 2025-04-13

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

RecruitingNCT06113237

Jazz PharmaceuticalsBirth Outcomes, Adverse, Maternal Complications, Pregnancy +1

Start: 2025-08-05End: 2033-08-31Target: 50Updated: 2026-03-18

Related Papers

Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support

Translational Psychiatry2026-01-30

Cannabidiol (CBD) Treatment for Severe Problem Behaviors in Autistic Boys: A Randomized Clinical Trial

Journal of Autism and Developmental Disorders2025-05-245 citations

The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy

Neurocase2017-10-2424 citations